- Published at
- by gurufocus.com
mixed
mixed
Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. ( IKNA) (”Ikena”) and Inmagene Biopharmaceuticals (”Inmagene”) today anno